Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Dysport and Mesport for blepharospasm
IRCT20250102064249N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in idiopathic blepharospasm (BEB) (2 arms), sponsored by Tehran University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on IRCT20250102064249N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250102064249N1.